Esra Dönmez
Research Subjects
Esra Dönmez has a total of 69 co-authors. Here are the top co-authors by number of shared publications:
- Sevgi Özcan
Department of Cardiology, Bagcılar Training and Research Hospital, İstanbul, Türkiye
11 shared publications - Ertuğrul Okuyan
Istanbul Medipol Üniversitesi
9 shared publications - İrFan Sahin
Department of Cardiology, Bağcılar Training and Research Hospital, University of Health Sciences, 34200 Istanbul, Türkiye
6 shared publications - Emirhan Hancıoğlu
Department of Cardiology, Medipol University School of Medicine, İstanbul 34083, Turkey
3 shared publications - Emre Melik Faideci
Department of Cardiology Bilecik Training and Research Hospital Bilecik Turkey
3 shared publications Ertuğrul Okuyan
Bağcılar Training and Research Hospital, Istanbul, Türkiye
3 shared publications
Latest Publications
- 19 November 2026
- Published by Wiley in Catheterization and Cardiovascular Interventions
Admission C‐Reactive Protein–Albumin–Lymphocyte Index and Risk Stratification for Contrast‐Associated Acute Kidney Injury in ST‐Segment Elevation Myocardial Infarction: Comparison With the Systemic Immune‐Inflammation Index
Background: Many blood‐based inflammatory and nutritional indices have been linked to contrast‐associated acute kidney injury (CA‐AKI) after primary percutaneous coronary intervention (PCI) for ST‐segment elevation myocardial infarction (STEMI), but they are rarely compared with one another or tested for what they add to existing risk models. The C‐reactive protein–albumin–lymphocyte (CALLY) index and the systemic immune‐inflammation index (SII) both come from routine admission blood tests, yet no study has compared them directly for CA‐AKI or asked whether CALLY adds anything to a standard clinical model. Aims: We tested whether CALLY predicts CA‐AKI independently of SII in STEMI, and whether it improves reclassification and net benefit on top of a full clinical model. Methods: In this retrospective cohort study, we reviewed 1561 consecutive STEMI patients treated with primary PCI between 2021 and 2025. CA‐AKI was defined by the KDIGO 48‐h criterion (creatinine rise ≥ 0.3 mg/dL), with creatinine measured daily in every patient. CALLY and ln(SII) were added, alone and together, to a prespecified clinical risk model. Models were compared with the DeLong test, continuous NRI, IDI, and decision‐curve analysis. Results: CA‐AKI developed in 317 patients (20.3%). CALLY discriminated CA‐AKI better than ln(SII) (AUC 0.632 vs. 0.559; DeLong p = 0.0003). When both were entered together, CALLY stayed independent (OR 0.872, 95% CI 0.783–0.970; p = 0.012), but ln(SII) did not ( p = 0.145), even though SII was independent on its own. Adding CALLY produced only a small change in the C‐statistic (0.752–0.762; DeLong non‐significant), yet it improved reclassification (IDI 0.007, p = 0.003; NRI 0.166, p = 0.005) and net benefit, and calibration remained adequate (Hosmer–Lemeshow p ≥ 0.249). Conclusion: In STEMI patients undergoing primary PCI, a low CALLY index was independently associated with CA‐AKI and improved risk reclassification when added to a clinical model, whereas SII was not independent once CALLY was included. This is the first comparison of CALLY and SII for CA‐AKI, and the first assessment of CALLY for CA‐AKI in STEMI.
- 19 November 2026
- Published by Wiley in Catheterization and Cardiovascular Interventions
Admission C‐Reactive Protein–Albumin–Lymphocyte Index and Risk Stratification for Contrast‐Associated Acute Kidney Injury in ST‐Segment Elevation Myocardial Infarction: Comparison With the Systemic Immune‐Inflammation Index
Background: Many blood‐based inflammatory and nutritional indices have been linked to contrast‐associated acute kidney injury (CA‐AKI) after primary percutaneous coronary intervention (PCI) for ST‐segment elevation myocardial infarction (STEMI), but they are rarely compared with one another or tested for what they add to existing risk models. The C‐reactive protein–albumin–lymphocyte (CALLY) index and the systemic immune‐inflammation index (SII) both come from routine admission blood tests, yet no study has compared them directly for CA‐AKI or asked whether CALLY adds anything to a standard clinical model. Aims: We tested whether CALLY predicts CA‐AKI independently of SII in STEMI, and whether it improves reclassification and net benefit on top of a full clinical model. Methods: In this retrospective cohort study, we reviewed 1561 consecutive STEMI patients treated with primary PCI between 2021 and 2025. CA‐AKI was defined by the KDIGO 48‐h criterion (creatinine rise ≥ 0.3 mg/dL), with creatinine measured daily in every patient. CALLY and ln(SII) were added, alone and together, to a prespecified clinical risk model. Models were compared with the DeLong test, continuous NRI, IDI, and decision‐curve analysis. Results: CA‐AKI developed in 317 patients (20.3%). CALLY discriminated CA‐AKI better than ln(SII) (AUC 0.632 vs. 0.559; DeLong p = 0.0003). When both were entered together, CALLY stayed independent (OR 0.872, 95% CI 0.783–0.970; p = 0.012), but ln(SII) did not ( p = 0.145), even though SII was independent on its own. Adding CALLY produced only a small change in the C‐statistic (0.752–0.762; DeLong non‐significant), yet it improved reclassification (IDI 0.007, p = 0.003; NRI 0.166, p = 0.005) and net benefit, and calibration remained adequate (Hosmer–Lemeshow p ≥ 0.249). Conclusion: In STEMI patients undergoing primary PCI, a low CALLY index was independently associated with CA‐AKI and improved risk reclassification when added to a clinical model, whereas SII was not independent once CALLY was included. This is the first comparison of CALLY and SII for CA‐AKI, and the first assessment of CALLY for CA‐AKI in STEMI.
- 27 March 2026
- Published by Wiley in Pacing and Clinical Electrophysiology
- Vol. 49 (9) , 1265-1272
Effect of Venous Tenting Puncture Technique on Complications in Cardiac Device Implantation via Axillary Access
Background: Axillary vein puncture (AVP) is an effective technique in cardiac implantable electronic device (CIED) implantation. This study evaluates the venous tenting (VnT) technique as a novel method and compares its effectiveness to contrast venography (CV) in reducing early and late complications. Methods: This retrospective multicenter study included 464 patients who underwent CIED implantation using VnT or CV techniques. Patients were matched 1:1 and divided into two groups: Group 1 ( n = 232) included those who underwent VnT, and Group 2 ( n = 232) included those who underwent CV. Early complications, including pneumothorax (PTX), pocket hematoma (PH), and pocket infection (PI), were collectively defined as total complications (TC). Late complications were defined as device lead integrity (DLI). Independent predictors of complications were identified using multivariate logistic regression analysis. Results: The TC rate was 5.2%. VnT significantly reduced PH rates (0.9% vs. 4.3%, p = 0.019) and TC rates (2.2% vs. 8.19%, p = 0.003) compared to CV. No significant differences were observed between the groups in PTX, PI, or DLI rates. Multivariate logistic regression analysis identified VnT as an independent protective factor for both TC ( p = 0.009) and PH ( p = 0.022). Conclusions: During CIED implantation, the VnT technique was associated with lower TC and PH than the CV technique. This study highlights the potential of VnT to improve outcomes. Further prospective studies are recommended to confirm these findings.
- 27 March 2026
- Published by Wiley in Pacing and Clinical Electrophysiology
- Vol. 49 (9) , 1265-1272
Effect of Venous Tenting Puncture Technique on Complications in Cardiac Device Implantation via Axillary Access
Background: Axillary vein puncture (AVP) is an effective technique in cardiac implantable electronic device (CIED) implantation. This study evaluates the venous tenting (VnT) technique as a novel method and compares its effectiveness to contrast venography (CV) in reducing early and late complications. Methods: This retrospective multicenter study included 464 patients who underwent CIED implantation using VnT or CV techniques. Patients were matched 1:1 and divided into two groups: Group 1 ( n = 232) included those who underwent VnT, and Group 2 ( n = 232) included those who underwent CV. Early complications, including pneumothorax (PTX), pocket hematoma (PH), and pocket infection (PI), were collectively defined as total complications (TC). Late complications were defined as device lead integrity (DLI). Independent predictors of complications were identified using multivariate logistic regression analysis. Results: The TC rate was 5.2%. VnT significantly reduced PH rates (0.9% vs. 4.3%, p = 0.019) and TC rates (2.2% vs. 8.19%, p = 0.003) compared to CV. No significant differences were observed between the groups in PTX, PI, or DLI rates. Multivariate logistic regression analysis identified VnT as an independent protective factor for both TC ( p = 0.009) and PH ( p = 0.022). Conclusions: During CIED implantation, the VnT technique was associated with lower TC and PH than the CV technique. This study highlights the potential of VnT to improve outcomes. Further prospective studies are recommended to confirm these findings.
- 20 October 2025
- Published by SAGE Publications in Angiology
- Vol. 77 (8) , 1036-1043
The Relation Between CHA2DS2-VASc Score, Initial TIMI Flow Grades and In-Hospital Mortality in Patients Presenting with Acute Myocardial Infarction
The CHA 2 DS 2 -VASc score includes classical risk factors (e.g., Congestive heart failure/Left ventricle dysfunction, Hypertension, Age, Diabetes mellitus, Stroke/Transient ischemic attack/Thromboembolism, Vascular disease and Sex) for coronary artery disease. We investigated the association between initial thrombolysis in myocardial infarction (TIMI) flow of the culprit artery and CHA 2 DS 2 -VASc score and in-hospital clinical outcomes in patients presenting with acute myocardial infarction (AMI). Initial and postprocedural TIMI flow grades were recorded in patients hospitalized with first diagnosis of AMI. The initial TIMI flow grades and CHA 2 DS 2 VASC scores were compared with the post-procedural TIMI flow grades. Patients (n = 750) were included retrospectively; 56.7% was in the low flow (TIMI 0-1) and 43.3% was in the high flow (TIMI 2-3) group. The CHA 2 DS 2 -VASc score was higher ( P < .001) in the low flow group. The best CHA 2 DS 2 -VASc score cut-off value was 3 to predict initial TIMI flow. Median CHA 2 DS 2 -VASc score was 4 in-hospital mortality group ( P < .001) and this score was an independent predictor of in-hospital mortality. The CHA 2 DS 2 -VASc score was an independent predictor of low initial TIMI flow and in-hospital mortality. Patients with high preprocedural CHA 2 DS 2 -VASc tended to have low coronary flow grades and higher mortality rates.
- 20 October 2025
- Published by SAGE Publications in Angiology
- Vol. 77 (8) , 1036-1043
The Relation Between CHA2DS2-VASc Score, Initial TIMI Flow Grades and In-Hospital Mortality in Patients Presenting with Acute Myocardial Infarction
The CHA 2 DS 2 -VASc score includes classical risk factors (e.g., Congestive heart failure/Left ventricle dysfunction, Hypertension, Age, Diabetes mellitus, Stroke/Transient ischemic attack/Thromboembolism, Vascular disease and Sex) for coronary artery disease. We investigated the association between initial thrombolysis in myocardial infarction (TIMI) flow of the culprit artery and CHA 2 DS 2 -VASc score and in-hospital clinical outcomes in patients presenting with acute myocardial infarction (AMI). Initial and postprocedural TIMI flow grades were recorded in patients hospitalized with first diagnosis of AMI. The initial TIMI flow grades and CHA 2 DS 2 VASC scores were compared with the post-procedural TIMI flow grades. Patients (n = 750) were included retrospectively; 56.7% was in the low flow (TIMI 0-1) and 43.3% was in the high flow (TIMI 2-3) group. The CHA 2 DS 2 -VASc score was higher ( P < .001) in the low flow group. The best CHA 2 DS 2 -VASc score cut-off value was 3 to predict initial TIMI flow. Median CHA 2 DS 2 -VASc score was 4 in-hospital mortality group ( P < .001) and this score was an independent predictor of in-hospital mortality. The CHA 2 DS 2 -VASc score was an independent predictor of low initial TIMI flow and in-hospital mortality. Patients with high preprocedural CHA 2 DS 2 -VASc tended to have low coronary flow grades and higher mortality rates.
- 24 September 2025
- Published by Springer Nature in The International Journal of Cardiovascular Imaging
- Vol. 41 (11) , 2183-2194
The relation between breast artery calcification and subclinical left ventricular systolic dysfunction
Cardiovascular diseases (CVD) are most common causes of mortality and morbidity. The presence of breast artery calcification (BAC) was shown to be associated with CVD. We aimed to determine the relationship between BAC and subclinical left ventricular systolic dysfunction (LVSD) by using strain echocardiography.Patients diagnosed with BAC between October 2023 and May 2024 were prospectively included. 100 age-matched patients without BAC were included as the control group. Patients were divided into two groups as BAC( +) and BAC(-) and further patients were grouped as LVSD( +) and LVSD(-) according to global longitudinal strain(GLS) measurements.A total of 94 patients with BAC( +) and 100 patients with BAC(-) were evaluated. When BAC(-) and BAC( +) groups were compared, GLS(-18.7 ± 2.6vs.-20.9 ± 1.7;p < 0.0001) was significantly lower in BAC( +) group and GLS was significantly decreased with increasing BAC grades (p < 0.0001). Significant deterioration in parameters indicating left ventricular diastolic function was observed in BAC ( +) group. BAC grade 3 (p = 0.002), increase in E/e' (p = 0.001), and NLr (p = 0.009) were identified as independent risk factors for LVSD. In the ROC analysis, a cut-off value of -17.3 for GLS was associated with 93.3% sensitivity of and 92.6%; specificity for predicting BAC grade 3.Presence of BAC is associated with subclinical LVSD and presence of BAC grade 3 is and independent predictor of LVSD. Detection BAC on screening mammograms may help to define patients under risk of heart failure development. Graphical Abstract
- 24 September 2025
- Published by Springer Nature in The International Journal of Cardiovascular Imaging
- Vol. 41 (11) , 2183-2194
The relation between breast artery calcification and subclinical left ventricular systolic dysfunction
Cardiovascular diseases (CVD) are most common causes of mortality and morbidity. The presence of breast artery calcification (BAC) was shown to be associated with CVD. We aimed to determine the relationship between BAC and subclinical left ventricular systolic dysfunction (LVSD) by using strain echocardiography.Patients diagnosed with BAC between October 2023 and May 2024 were prospectively included. 100 age-matched patients without BAC were included as the control group. Patients were divided into two groups as BAC( +) and BAC(-) and further patients were grouped as LVSD( +) and LVSD(-) according to global longitudinal strain(GLS) measurements.A total of 94 patients with BAC( +) and 100 patients with BAC(-) were evaluated. When BAC(-) and BAC( +) groups were compared, GLS(-18.7 ± 2.6vs.-20.9 ± 1.7;p < 0.0001) was significantly lower in BAC( +) group and GLS was significantly decreased with increasing BAC grades (p < 0.0001). Significant deterioration in parameters indicating left ventricular diastolic function was observed in BAC ( +) group. BAC grade 3 (p = 0.002), increase in E/e' (p = 0.001), and NLr (p = 0.009) were identified as independent risk factors for LVSD. In the ROC analysis, a cut-off value of -17.3 for GLS was associated with 93.3% sensitivity of and 92.6%; specificity for predicting BAC grade 3.Presence of BAC is associated with subclinical LVSD and presence of BAC grade 3 is and independent predictor of LVSD. Detection BAC on screening mammograms may help to define patients under risk of heart failure development. Graphical Abstract
- 15 April 2025
- Published by Wiley in Catheterization and Cardiovascular Interventions
- Vol. 106 (1) , 233-241
Could Right Coronary Artery‐Aorta Angle be Used to Predict Atherosclerotic Lesion Localization in Critical Site of the Right Coronary Artery in Patients With Right Dominancy?
Background: This study aimed to evaluate the impact of the aorta‐right coronary artery angle (ARA) on lesion localization and its protective effect in the critical osteal region in patients with dominant right coronary artery (RCA). Methods: This cross‐sectional study included 294 patients who underwent elective coronary angiography for stable angina pectoris and had a single significant lumen stenosis (50%–95%) before the RCA crux. Patients with tortuous vessels, previous interventions, left‐dominant circulation, or insufficient image quality were excluded. ARA, lesion criticality, length, and distance from the aorto‐osteal junction were calculated using quantitative coronary analysis. Patients were categorized based on lesion location: osteal, proximal, mid, and distal regions. Results: ARA increased significantly as the lesion localization moved distally (osteal: 53.26° ± 5.65°, proximal: 60.79° ± 9.53°, mid: 82.33° ± 9.85°, distal: 93.53° ± 7.46°; p < 0.0001). A strong positive correlation was found between ARA and the distance of the lesion from the aorto‐osteal junction ( r = 0.759, p < 0.0001). In binary regression, ARA was the only independent risk factor for critical lesion localization in the osteal region (OR = 0.915; 95% CI 0.868–0.965, p < 0.001). ROC analysis showed that an ARA > 73.50° had 83.2% sensitivity and 81.3% specificity for excluding critical lesions in the osteal region (AUC = 0.861; 95% CI 0.815–0.907). Conclusion: A narrow ARA increases the likelihood of critical lesions in the osteal RCA, while an ARA > 73.50° is protective. These findings suggest ARA could guide risk assessment and treatment planning in coronary interventions.
- 15 April 2025
- Published by Wiley in Catheterization and Cardiovascular Interventions
- Vol. 106 (1) , 233-241
Could Right Coronary Artery‐Aorta Angle be Used to Predict Atherosclerotic Lesion Localization in Critical Site of the Right Coronary Artery in Patients With Right Dominancy?
Background: This study aimed to evaluate the impact of the aorta‐right coronary artery angle (ARA) on lesion localization and its protective effect in the critical osteal region in patients with dominant right coronary artery (RCA). Methods: This cross‐sectional study included 294 patients who underwent elective coronary angiography for stable angina pectoris and had a single significant lumen stenosis (50%–95%) before the RCA crux. Patients with tortuous vessels, previous interventions, left‐dominant circulation, or insufficient image quality were excluded. ARA, lesion criticality, length, and distance from the aorto‐osteal junction were calculated using quantitative coronary analysis. Patients were categorized based on lesion location: osteal, proximal, mid, and distal regions. Results: ARA increased significantly as the lesion localization moved distally (osteal: 53.26° ± 5.65°, proximal: 60.79° ± 9.53°, mid: 82.33° ± 9.85°, distal: 93.53° ± 7.46°; p < 0.0001). A strong positive correlation was found between ARA and the distance of the lesion from the aorto‐osteal junction ( r = 0.759, p < 0.0001). In binary regression, ARA was the only independent risk factor for critical lesion localization in the osteal region (OR = 0.915; 95% CI 0.868–0.965, p < 0.001). ROC analysis showed that an ARA > 73.50° had 83.2% sensitivity and 81.3% specificity for excluding critical lesions in the osteal region (AUC = 0.861; 95% CI 0.815–0.907). Conclusion: A narrow ARA increases the likelihood of critical lesions in the osteal RCA, while an ARA > 73.50° is protective. These findings suggest ARA could guide risk assessment and treatment planning in coronary interventions.
- 3 March 2025
- Published by Taylor & Francis in Biomarkers in Medicine
- Vol. 19 (6) , 187-195
The relationship between serum Lumican levels and myocardial fibrosis in patients with hypertrophic cardiomyopathy
Hypertrophic cardiomyopathy (HCM) is the leading cause of sudden cardiac death in young individuals. Lumican, is an indicator of fibrosis. We aimed to evaluate the relation between serum Lumican levels and presence and extent of myocardial fibrosis in HCM. The patients diagnosed with HCM between June 2022 and March 2023 were enrolled consecutively in this prospective study. Age and gender-matched healthy individuals formed control group. Two groups were generated according to extent of late gadolinium enhancement (LGE) in HCM patients. A total of 114 patients were enrolled. Serum Lumican, NT-proBNP levels and maximum wall thickness were revealed as independent risk factors associated with LGE. A cut-off value of 9.06 for Lumican was associated with 67.8% sensitivity and 65.5% specificity in prediction of LGE. Myocardial fibrosis is one of the important mechanisms in HCM pathophysiology. LGE on cardiac magnetic resonance imaging allows comprehensive evaluation of myocardial fibrosis, the support of diagnosis with a biomarker would be beneficial in clinical practice. Our study revealed that serum Lumican level is an independent predictor of severe LGE in HCM patients. Further studies with larger patient numbers may clarify the importance of Lumican in HCM pathophysiology.
- 3 March 2025
- Published by Taylor & Francis in Biomarkers in Medicine
- Vol. 19 (6) , 187-195
The relationship between serum Lumican levels and myocardial fibrosis in patients with hypertrophic cardiomyopathy
Hypertrophic cardiomyopathy (HCM) is the leading cause of sudden cardiac death in young individuals. Lumican, is an indicator of fibrosis. We aimed to evaluate the relation between serum Lumican levels and presence and extent of myocardial fibrosis in HCM. The patients diagnosed with HCM between June 2022 and March 2023 were enrolled consecutively in this prospective study. Age and gender-matched healthy individuals formed control group. Two groups were generated according to extent of late gadolinium enhancement (LGE) in HCM patients. A total of 114 patients were enrolled. Serum Lumican, NT-proBNP levels and maximum wall thickness were revealed as independent risk factors associated with LGE. A cut-off value of 9.06 for Lumican was associated with 67.8% sensitivity and 65.5% specificity in prediction of LGE. Myocardial fibrosis is one of the important mechanisms in HCM pathophysiology. LGE on cardiac magnetic resonance imaging allows comprehensive evaluation of myocardial fibrosis, the support of diagnosis with a biomarker would be beneficial in clinical practice. Our study revealed that serum Lumican level is an independent predictor of severe LGE in HCM patients. Further studies with larger patient numbers may clarify the importance of Lumican in HCM pathophysiology.
- Open Access
- 1 January 2025
- Published by Sociedade Brasileira de Cirurgia Cardiovascular in Brazilian Journal of Cardiovascular Surgery
- Vol. 40 (6)
Preoperative Uric Acid-to-Albumin Ratio as a Predictor of Postoperative Atrial Fibrillation After Cardiac Surgery
Postoperative atrial fibrillation (POAF), the pathophysiology that includes inflammation and oxidative stress, is associated with increased hospital length of stay, mortality, and complications. The uric acid-to-albumin ratio reflects the inflammatory status of the body. We sought to evaluate whether there is an association between POAF and uric acid-to-albumin ratio in patients undergoing cardiac surgery. Five hundred forty-three patients who developed POAF and 166 patients who did not formed our control and study groups, respectively. Patients who had an episode of atrial fibrillation lasting > 30 seconds were considered to have POAF. The uric acid-to-albumin ratio was calculated for each patient. Patients who developed POAF were older; had higher rates of hypertension, carotid artery disease, left atrial diameter, urea, creatinine, uric acid, and C-reactive protein levels; and had lower hemoglobin and albumin levels. The uric acid-to-albumin ratio of patients with and without POAF was 1.65 ± 0.63 and 1.26 ± 0.39, respectively (P < 0.001). Compared with uric acid and albumin, uric acid-to-albumin ratio had the highest area under the curve for predicting POAF (0.681, 0.449, and 0.702, respectively). Age and hemoglobin concentration were predictors of POAF. Although uric acid and albumin did not reach statistical significance for predicting POAF, the uric acid-to-albumin ratio had predictive value for the development of POAF. The ability of the uric acid-to-albumin ratio to predict POAF in cardiac surgery patients and its nonnegligible benefits justify its use in clinical practice.
- 1 January 2025
- Published by Sociedade Brasileira de Cirurgia Cardiovascular in Brazilian Journal of Cardiovascular Surgery
- Vol. 40 (6)
Open AccessPreoperative Uric Acid-to-Albumin Ratio as a Predictor of Postoperative Atrial Fibrillation After Cardiac Surgery
Postoperative atrial fibrillation (POAF), the pathophysiology that includes inflammation and oxidative stress, is associated with increased hospital length of stay, mortality, and complications. The uric acid-to-albumin ratio reflects the inflammatory status of the body. We sought to evaluate whether there is an association between POAF and uric acid-to-albumin ratio in patients undergoing cardiac surgery. Five hundred forty-three patients who developed POAF and 166 patients who did not formed our control and study groups, respectively. Patients who had an episode of atrial fibrillation lasting > 30 seconds were considered to have POAF. The uric acid-to-albumin ratio was calculated for each patient. Patients who developed POAF were older; had higher rates of hypertension, carotid artery disease, left atrial diameter, urea, creatinine, uric acid, and C-reactive protein levels; and had lower hemoglobin and albumin levels. The uric acid-to-albumin ratio of patients with and without POAF was 1.65 ± 0.63 and 1.26 ± 0.39, respectively (P < 0.001). Compared with uric acid and albumin, uric acid-to-albumin ratio had the highest area under the curve for predicting POAF (0.681, 0.449, and 0.702, respectively). Age and hemoglobin concentration were predictors of POAF. Although uric acid and albumin did not reach statistical significance for predicting POAF, the uric acid-to-albumin ratio had predictive value for the development of POAF. The ability of the uric acid-to-albumin ratio to predict POAF in cardiac surgery patients and its nonnegligible benefits justify its use in clinical practice.
- 29 December 2023
- Published by VM Media Group sp. z o.o in Acta Angiologica
- Vol. 29 (4) , 133-140
Comparing two risk scores for predictive ability of contrast-induced nephropathy development in patients presenting with chronic coronary syndrome
Introduction: This study aimed to investigate the roles of ATRIA and CHA2DS2-VASc scores in predicting contrast-induced nephropathy (CIN) development risk in patients presenting with chronic coronary syndromes (CCS) and undergoing elective percutaneous coronary intervention (PCI). Material and methods: Patients who underwent coronary angiography due to diagnosis of CCS and decided to be treated with PCI between 2018 and 2020 were included in this retrospective single-centre study. Results: A total of 447 patients were included. DM [p < 0.0001, β: 0.263, OR (95%CI): 0.187–0.459], CHF [p = 0.035, β: 0.384, OR (95%CI): 0.158–0.934], the volume of CA [p = 0.020, β: 0.145, OR (95%CI): 0.112–0.393], ATRIA [p = 0.001, β: 3.453, OR (95%CI): 1.132–6.148] and CHA2DS2-VASc [p < 0.0001, β: 3.120, OR (95%CI): 1.925–5.056] scores were found as independent risk factors associated with CIN development. The AUC for the ATRIA score was 0.779 [%95CI: 0.717–0.842]. A cutoff value of 4.5 for the ATRIA score was associated with 74.1% sensitivity and 67.3% specificity in the prediction of CIN development. Moreover, the AUC for the CHA2DS2-VASc score was 0.869 [%95CI: 0.825–0.912]. A cutoff value of 3.5 for the CHA2DS2-VASc score was associated with 81.5% sensitivity and 76.1% specificity in the prediction of CIN development. Conclusion: ATRIA and CHA2DS2-VASc scores may be used as a marker of CIN development in CCS patients who underwent elective PCI and both scores may be used to define patients under risk in a practical way. Introduction: This study aimed to investigate the roles of ATRIA and CHA2DS2-VASc scores in predicting contrast-induced nephropathy (CIN) development risk in patients presenting with chronic coronary syndromes (CCS) and undergoing elective percutaneous coronary intervention (PCI). Material and methods: Patients who underwent coronary angiography due to diagnosis of CCS and decided to be treated with PCI between 2018 and 2020 were included in this retrospective single-centre study. Results: A total of 447 patients were included. DM [p < 0.0001, β: 0.263, OR (95%CI): 0.187–0.459], CHF [p = 0.035, β: 0.384, OR (95%CI): 0.158–0.934], the volume of CA [p = 0.020, β: 0.145, OR (95%CI): 0.112–0.393], ATRIA [p = 0.001, β: 3.453, OR (95%CI): 1.132–6.148] and CHA2DS2-VASc [p < 0.0001, β: 3.120, OR (95%CI): 1.925–5.056] scores were found as independent risk factors associated with CIN development. The AUC for the ATRIA score was 0.779 [%95CI: 0.717–0.842]. A cutoff value of 4.5 for the ATRIA score was associated with 74.1% sensitivity and 67.3% specificity in the prediction of CIN development. Moreover, the AUC for the CHA2DS2-VASc score was 0.869 [%95CI: 0.825–0.912]. A cutoff value of 3.5 for the CHA2DS2-VASc score was associated with 81.5% sensitivity and 76.1% specificity in the prediction of CIN development. Conclusion: ATRIA and CHA2DS2-VASc scores may be used as a marker of CIN development in CCS patients who underwent elective PCI and both scores may be used to define patients under risk in a practical way.
- 29 December 2023
- Published by VM Media Group sp. z o.o in Acta Angiologica
- Vol. 29 (4) , 133-140
Comparing two risk scores for predictive ability of contrast-induced nephropathy development in patients presenting with chronic coronary syndrome
Introduction: This study aimed to investigate the roles of ATRIA and CHA2DS2-VASc scores in predicting contrast-induced nephropathy (CIN) development risk in patients presenting with chronic coronary syndromes (CCS) and undergoing elective percutaneous coronary intervention (PCI). Material and methods: Patients who underwent coronary angiography due to diagnosis of CCS and decided to be treated with PCI between 2018 and 2020 were included in this retrospective single-centre study. Results: A total of 447 patients were included. DM [p < 0.0001, β: 0.263, OR (95%CI): 0.187–0.459], CHF [p = 0.035, β: 0.384, OR (95%CI): 0.158–0.934], the volume of CA [p = 0.020, β: 0.145, OR (95%CI): 0.112–0.393], ATRIA [p = 0.001, β: 3.453, OR (95%CI): 1.132–6.148] and CHA2DS2-VASc [p < 0.0001, β: 3.120, OR (95%CI): 1.925–5.056] scores were found as independent risk factors associated with CIN development. The AUC for the ATRIA score was 0.779 [%95CI: 0.717–0.842]. A cutoff value of 4.5 for the ATRIA score was associated with 74.1% sensitivity and 67.3% specificity in the prediction of CIN development. Moreover, the AUC for the CHA2DS2-VASc score was 0.869 [%95CI: 0.825–0.912]. A cutoff value of 3.5 for the CHA2DS2-VASc score was associated with 81.5% sensitivity and 76.1% specificity in the prediction of CIN development. Conclusion: ATRIA and CHA2DS2-VASc scores may be used as a marker of CIN development in CCS patients who underwent elective PCI and both scores may be used to define patients under risk in a practical way. Introduction: This study aimed to investigate the roles of ATRIA and CHA2DS2-VASc scores in predicting contrast-induced nephropathy (CIN) development risk in patients presenting with chronic coronary syndromes (CCS) and undergoing elective percutaneous coronary intervention (PCI). Material and methods: Patients who underwent coronary angiography due to diagnosis of CCS and decided to be treated with PCI between 2018 and 2020 were included in this retrospective single-centre study. Results: A total of 447 patients were included. DM [p < 0.0001, β: 0.263, OR (95%CI): 0.187–0.459], CHF [p = 0.035, β: 0.384, OR (95%CI): 0.158–0.934], the volume of CA [p = 0.020, β: 0.145, OR (95%CI): 0.112–0.393], ATRIA [p = 0.001, β: 3.453, OR (95%CI): 1.132–6.148] and CHA2DS2-VASc [p < 0.0001, β: 3.120, OR (95%CI): 1.925–5.056] scores were found as independent risk factors associated with CIN development. The AUC for the ATRIA score was 0.779 [%95CI: 0.717–0.842]. A cutoff value of 4.5 for the ATRIA score was associated with 74.1% sensitivity and 67.3% specificity in the prediction of CIN development. Moreover, the AUC for the CHA2DS2-VASc score was 0.869 [%95CI: 0.825–0.912]. A cutoff value of 3.5 for the CHA2DS2-VASc score was associated with 81.5% sensitivity and 76.1% specificity in the prediction of CIN development. Conclusion: ATRIA and CHA2DS2-VASc scores may be used as a marker of CIN development in CCS patients who underwent elective PCI and both scores may be used to define patients under risk in a practical way.
- Open Access
- 14 August 2023
- Published by Walter de Gruyter GmbH in Advances in Laboratory Medicine / Avances en Medicina de Laboratorio
- Vol. 4 (3) , 308-313
The association between hemogram parameters and the development of contrast-induced nephropathy in patients presenting with non-ST-elevation myocardial infarction
Objectives: Hemogram parameters such as mean platelet volume (MPV), neutrophil/lymphocyte ratio (NLr), red cell distribution width and platelet distribution width are widely used inflammatory indicators to assess prognosis in various cardiovascular diseases. In this study, we aimed to investigate the role of hemogram parameters to predict the development of contrast-induced nephropathy (CIN) in patients presenting with non-ST segment elevation myocardial infarction (non-STEMI) and treated with percutaneous coronary intervention (PCI). Methods: All pateints who underwent PCI with a diagnosis of non-STEMI between 2017 and 2020 in our center were included retrospectively in this study. Results: A total of 387 patients were included in this retrospective study. Advanced age (p=0.001, β:0.005, OR [95 % CI]: 0.002–0.007), diabetes mellitus (p=0.013, β:0.205, OR [95 % CI]: 0.150–0.260), congestive heart failure (p=0.009, β:0.095, OR [95 % CI]: 0.024–0.166), volume of contrast medium (p=0.008, β:0.241, OR [95 % CI]: 0.184–0.392), MPV (p=0.02, β:0.047, OR [95 % CI]: 0.028–0.065) and NLr (p=0.001, β:0.052, OR [95 % CI]: 0.040–0.063) were found as independent risk factors associated with CIN development according to multivariate logistic regression analysis. A cut off value of 5.5 for NLr was associated with 79.6 % sensitivity and 79.5 % specificity and 9.05 for MPV was associated with 64.1 % sensitivity and 58.7 % specificity in prediction of CIN development. Conclusions: Hematological parameters, assessed by routine blood count analysis may serve as a promising and useful marker for CIN especially when used in combination with traditional risk factors. MPV and NLr were demonstrated as predictors of CIN development in non-STEMI patients who were treated with PCI in our study.
- 14 August 2023
- Published by Walter de Gruyter GmbH in Advances in Laboratory Medicine / Avances en Medicina de Laboratorio
- Vol. 4 (3) , 308-313
Open AccessThe association between hemogram parameters and the development of contrast-induced nephropathy in patients presenting with non-ST-elevation myocardial infarction
Objectives: Hemogram parameters such as mean platelet volume (MPV), neutrophil/lymphocyte ratio (NLr), red cell distribution width and platelet distribution width are widely used inflammatory indicators to assess prognosis in various cardiovascular diseases. In this study, we aimed to investigate the role of hemogram parameters to predict the development of contrast-induced nephropathy (CIN) in patients presenting with non-ST segment elevation myocardial infarction (non-STEMI) and treated with percutaneous coronary intervention (PCI). Methods: All pateints who underwent PCI with a diagnosis of non-STEMI between 2017 and 2020 in our center were included retrospectively in this study. Results: A total of 387 patients were included in this retrospective study. Advanced age (p=0.001, β:0.005, OR [95 % CI]: 0.002–0.007), diabetes mellitus (p=0.013, β:0.205, OR [95 % CI]: 0.150–0.260), congestive heart failure (p=0.009, β:0.095, OR [95 % CI]: 0.024–0.166), volume of contrast medium (p=0.008, β:0.241, OR [95 % CI]: 0.184–0.392), MPV (p=0.02, β:0.047, OR [95 % CI]: 0.028–0.065) and NLr (p=0.001, β:0.052, OR [95 % CI]: 0.040–0.063) were found as independent risk factors associated with CIN development according to multivariate logistic regression analysis. A cut off value of 5.5 for NLr was associated with 79.6 % sensitivity and 79.5 % specificity and 9.05 for MPV was associated with 64.1 % sensitivity and 58.7 % specificity in prediction of CIN development. Conclusions: Hematological parameters, assessed by routine blood count analysis may serve as a promising and useful marker for CIN especially when used in combination with traditional risk factors. MPV and NLr were demonstrated as predictors of CIN development in non-STEMI patients who were treated with PCI in our study.